Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris R Triggle

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|January 5, 2008
The early effects of elevated glucose on endothelial function as a target in the treatment of type 2 diabetesChris R Triggle
Timely Topics in Medicine. Cardiovascular Diseases|April 9, 2008
The early effects of elevated glucose on endothelial function as a target in the treatment of type 2 diabetesChris R Triggle
Biochemical Pharmacology|July 28, 2015
The answer is not 42Chris R Triggle
Clinical and Experimental Pharmacology & Physiology|March 22, 2002
Endothelium-derived hyperpolarizing factor: is there a novel chemical mediator?Chris R Triggle, Hong Ding
Vascular Health and Risk Management|February 27, 2007
Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endotheliumHong Ding, Chris R Triggle
Pflugers Archiv : European Journal of Physiology|March 19, 2010
Endothelial dysfunction in diabetes: multiple targets for treatmentHong Ding, Chris R Triggle
Viruses|July 30, 2025
COVID-19 and a Tale of Three Drugs: To Repurpose, or Not to Repurpose-That Was the QuestionChris R Triggle, Ross MacDonald
Frontiers in Bioscience (Scholar Edition)|January 4, 2011
The endothelium in compliance and resistance vesselsChris R Triggle, Hong Ding
Journal of the American Society of Hypertension : JASH|May 18, 2010
A review of endothelial dysfunction in diabetes: a focus on the contribution of a dysfunctional eNOSChris R Triggle, Hong Ding
Therapeutic Advances in Chronic Disease|November 4, 2014
Cardiovascular impact of drugs used in the treatment of diabetesChris R Triggle, Hong Ding
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Drugs of Today (Barcelona, Spain : 1998)|January 5, 2008
The early effects of elevated glucose on endothelial function as a target in the treatment of type 2 diabetesChris R Triggle
Timely Topics in Medicine. Cardiovascular Diseases|April 9, 2008
The early effects of elevated glucose on endothelial function as a target in the treatment of type 2 diabetesChris R Triggle
Biochemical Pharmacology|July 28, 2015
The answer is not 42Chris R Triggle
Clinical and Experimental Pharmacology & Physiology|March 22, 2002
Endothelium-derived hyperpolarizing factor: is there a novel chemical mediator?Chris R Triggle, Hong Ding
Vascular Health and Risk Management|February 27, 2007
Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endotheliumHong Ding, Chris R Triggle
Pflugers Archiv : European Journal of Physiology|March 19, 2010
Endothelial dysfunction in diabetes: multiple targets for treatmentHong Ding, Chris R Triggle
Viruses|July 30, 2025
COVID-19 and a Tale of Three Drugs: To Repurpose, or Not to Repurpose-That Was the QuestionChris R Triggle, Ross MacDonald
Frontiers in Bioscience (Scholar Edition)|January 4, 2011
The endothelium in compliance and resistance vesselsChris R Triggle, Hong Ding
Journal of the American Society of Hypertension : JASH|May 18, 2010
A review of endothelial dysfunction in diabetes: a focus on the contribution of a dysfunctional eNOSChris R Triggle, Hong Ding
Therapeutic Advances in Chronic Disease|November 4, 2014
Cardiovascular impact of drugs used in the treatment of diabetesChris R Triggle, Hong Ding
Pageof 8